1. Home
  2. KZIA vs XWEL Comparison

KZIA vs XWEL Comparison

Compare KZIA & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • XWEL
  • Stock Information
  • Founded
  • KZIA 1994
  • XWEL 2006
  • Country
  • KZIA Australia
  • XWEL United States
  • Employees
  • KZIA N/A
  • XWEL N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • XWEL Other Consumer Services
  • Sector
  • KZIA Health Care
  • XWEL Consumer Discretionary
  • Exchange
  • KZIA Nasdaq
  • XWEL Nasdaq
  • Market Cap
  • KZIA 6.0M
  • XWEL 9.0M
  • IPO Year
  • KZIA 1999
  • XWEL N/A
  • Fundamental
  • Price
  • KZIA $0.90
  • XWEL $1.14
  • Analyst Decision
  • KZIA Strong Buy
  • XWEL
  • Analyst Count
  • KZIA 2
  • XWEL 0
  • Target Price
  • KZIA $11.50
  • XWEL N/A
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • XWEL 12.1K
  • Earning Date
  • KZIA 03-26-2025
  • XWEL 11-14-2024
  • Dividend Yield
  • KZIA N/A
  • XWEL N/A
  • EPS Growth
  • KZIA N/A
  • XWEL N/A
  • EPS
  • KZIA N/A
  • XWEL N/A
  • Revenue
  • KZIA $1,655,324.00
  • XWEL $33,833,000.00
  • Revenue This Year
  • KZIA N/A
  • XWEL $22.75
  • Revenue Next Year
  • KZIA N/A
  • XWEL N/A
  • P/E Ratio
  • KZIA N/A
  • XWEL N/A
  • Revenue Growth
  • KZIA 248000.00
  • XWEL 11.79
  • 52 Week Low
  • KZIA $0.87
  • XWEL $1.14
  • 52 Week High
  • KZIA $15.80
  • XWEL $2.70
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 29.40
  • XWEL 35.50
  • Support Level
  • KZIA $0.90
  • XWEL $1.17
  • Resistance Level
  • KZIA $1.60
  • XWEL $1.19
  • Average True Range (ATR)
  • KZIA 0.23
  • XWEL 0.04
  • MACD
  • KZIA 0.01
  • XWEL 0.00
  • Stochastic Oscillator
  • KZIA 1.53
  • XWEL 0.00

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About XWEL XWELL Inc.

XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.

Share on Social Networks: